InvestorsHub Logo
Followers 22
Posts 3527
Boards Moderated 0
Alias Born 10/15/2016

Re: jamesnhansen post# 35889

Tuesday, 02/23/2021 1:31:51 AM

Tuesday, February 23, 2021 1:31:51 AM

Post# of 43784
@james

Once I became resigned to the "wait for the full report" instead of "here's the top-line results" then the entire process of science started to bubble in my thoughts, and it is not fast. So many things to account for, possibly follow up on in more ways than writing a report...

Pretty sure we are also evaluating tissue samples. Maybe that was pre-defined and could be done along the way, or maybe it has to be looked at or looked at all over again at the end. I imagine that can be tedious, especially when you factor in "ok, this guy has these gene markers, that guy has those..." The volume of data there has to be far in excess of some paper report, to includes slides, samples, and tons more reports.

A full scientific report has got to be rather grueling, we cracked open a lot of new things to be studied and documented with this study.

Also, possibly several scientific papers may come of this, not just one.

Then there is the auxiliary arm that "the FDA wanted", perhaps simply as an additional control, but figure if there is any difference in CIZ + MK vs. just MK then that is a whole research project right there.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News